New Molecular Avenues in Parkinson’s Disease Therapy

E-ISSN： 1873-4294|9|10|913-948

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.10, 2009-07, pp. : 913-948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transplantation therapy for Parkinson’s disease

By Borlongan C.V.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2319-2330

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for Parkinson’s disease: review and update

By Kang U.J. Frim D.M.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1551-1564

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1083-1085

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection for Parkinson’s disease: a new approach for a new millennium

By Drukarch Benjamin van Muiswinkel Freek L

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1855-1868

Informa Healthcare

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl Henchcliffe Claire

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite